Epilepsy Treatment May Alleviate Migraines
A Swedish study has shown that Lamotrigine, a medication originally used to treat epilepsy and bipolar disorder, can significantly reduce the number of days of aura associated with migraines. The duration of aura decreased by 80% in patients. The average number of aura days per month before treatment was 6.9 days, which dropped to 1.4 days after treatment, with 85.2% of patients responding to the therapy. Despite these promising results, the study was retrospective and requires larger clinical trials to confirm its effectiveness as a treatment for aura in migraines.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)